These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22204526)

  • 1. An estimation method of the clearance for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2012; 22(1):43-53. PubMed ID: 22204526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An estimation method of the half-life for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I; Yafune A
    J Biopharm Stat; 2007; 17(5):827-37. PubMed ID: 17885868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.
    Chiou WL; Huang SM; Huang YC
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):1-4. PubMed ID: 7364527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
    Haug KG; Weber B; Hochhaus G; Butterweck V
    Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A probabilistic approach to the single-point, single-dose problem.
    Briggs WL; Phelps RW; Swanson GD
    IEEE Trans Biomed Eng; 1990 Jan; 37(1):80-4. PubMed ID: 2303274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generalized equations for multiple dose kinetics by i.v. injection.
    Hajratwala BR
    Pharmazie; 1976; 31(10):731-3. PubMed ID: 1019197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug concentration-time data in humans from animals: a comparison of three methods.
    Mahmood I; Goteti K
    Xenobiotica; 2012 Aug; 42(8):756-65. PubMed ID: 22360447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of Bayesian estimation of pharmacokinetic parameters.
    Tsuchiwata S; Mihara K; Yafune A; Ogata H
    Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Feb; 102(2):761-71. PubMed ID: 23233148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of population pharmacokinetic parameters using destructively obtained experimental data: a simulation study of the one-compartment open model.
    Lindstrom FT; Birkes DS
    Drug Metab Rev; 1984; 15(1-2):195-264. PubMed ID: 6745082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elementary pharmacokinetics in clinical practice. 3: Practical pharmacokinetic applications.
    Paxton JW
    N Z Med J; 1981 Nov; 94(696):381-4. PubMed ID: 6948206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.